ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancers Immunotherapy Drugs Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-29O13402
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancers Immunotherapy Drugs Market Research Report 2023
BUY CHAPTERS

Global Cancers Immunotherapy Drugs Market Research Report 2025

Code: QYRE-Auto-29O13402
Report
June 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Pfizer Inc
Merck
Novartis
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Amgen Inc
AbbVie
Boehringer Ingelheim
Astrazeneca plc
Immatics Biotechnologies

Cancers Immunotherapy Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cancers Immunotherapy Drugs Market

Cancers Immunotherapy Drugs Market

The global market for Cancers Immunotherapy Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancers Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancers Immunotherapy Drugs.
The Cancers Immunotherapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancers Immunotherapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancers Immunotherapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancers Immunotherapy Drugs Market Report

Report Metric Details
Report Name Cancers Immunotherapy Drugs Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Pfizer, Merck, Novartis, Johnson & Johnson, Sanofi, GlaxoSmithKline, Amgen, AbbVie, Boehringer Ingelheim, AstraZeneca, Immatics Biotechnologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancers Immunotherapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancers Immunotherapy Drugs Market report?

Ans: The main players in the Cancers Immunotherapy Drugs Market are Roche, Pfizer, Merck, Novartis, Johnson & Johnson, Sanofi, GlaxoSmithKline, Amgen, AbbVie, Boehringer Ingelheim, AstraZeneca, Immatics Biotechnologies

What are the Application segmentation covered in the Cancers Immunotherapy Drugs Market report?

Ans: The Applications covered in the Cancers Immunotherapy Drugs Market report are Lung Cancer, Liver Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Other Cancers

What are the Type segmentation covered in the Cancers Immunotherapy Drugs Market report?

Ans: The Types covered in the Cancers Immunotherapy Drugs Market report are Monoclonal Antibodies, Check Point Inhibitors, Interferons, Interleukins

Recommended Reports

Cancer Drug Therapy

Cancer Diagnostics

Specific Cancer Types

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Check Point Inhibitors
1.2.4 Interferons
1.2.5 Interleukins
1.3 Market by Application
1.3.1 Global Cancers Immunotherapy Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Liver Cancer
1.3.4 Colorectal Cancer
1.3.5 Pancreatic Cancer
1.3.6 Breast Cancer
1.3.7 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancers Immunotherapy Drugs Market Perspective (2020-2031)
2.2 Global Cancers Immunotherapy Drugs Growth Trends by Region
2.2.1 Global Cancers Immunotherapy Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancers Immunotherapy Drugs Historic Market Size by Region (2020-2025)
2.2.3 Cancers Immunotherapy Drugs Forecasted Market Size by Region (2026-2031)
2.3 Cancers Immunotherapy Drugs Market Dynamics
2.3.1 Cancers Immunotherapy Drugs Industry Trends
2.3.2 Cancers Immunotherapy Drugs Market Drivers
2.3.3 Cancers Immunotherapy Drugs Market Challenges
2.3.4 Cancers Immunotherapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancers Immunotherapy Drugs Players by Revenue
3.1.1 Global Top Cancers Immunotherapy Drugs Players by Revenue (2020-2025)
3.1.2 Global Cancers Immunotherapy Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Cancers Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancers Immunotherapy Drugs Revenue
3.4 Global Cancers Immunotherapy Drugs Market Concentration Ratio
3.4.1 Global Cancers Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancers Immunotherapy Drugs Revenue in 2024
3.5 Global Key Players of Cancers Immunotherapy Drugs Head office and Area Served
3.6 Global Key Players of Cancers Immunotherapy Drugs, Product and Application
3.7 Global Key Players of Cancers Immunotherapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancers Immunotherapy Drugs Breakdown Data by Type
4.1 Global Cancers Immunotherapy Drugs Historic Market Size by Type (2020-2025)
4.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Type (2026-2031)
5 Cancers Immunotherapy Drugs Breakdown Data by Application
5.1 Global Cancers Immunotherapy Drugs Historic Market Size by Application (2020-2025)
5.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancers Immunotherapy Drugs Market Size (2020-2031)
6.2 North America Cancers Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancers Immunotherapy Drugs Market Size by Country (2020-2025)
6.4 North America Cancers Immunotherapy Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancers Immunotherapy Drugs Market Size (2020-2031)
7.2 Europe Cancers Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancers Immunotherapy Drugs Market Size by Country (2020-2025)
7.4 Europe Cancers Immunotherapy Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancers Immunotherapy Drugs Market Size (2020-2031)
8.2 Asia-Pacific Cancers Immunotherapy Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancers Immunotherapy Drugs Market Size (2020-2031)
9.2 Latin America Cancers Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancers Immunotherapy Drugs Market Size by Country (2020-2025)
9.4 Latin America Cancers Immunotherapy Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancers Immunotherapy Drugs Market Size (2020-2031)
10.2 Middle East & Africa Cancers Immunotherapy Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cancers Immunotherapy Drugs Introduction
11.1.4 Roche Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Cancers Immunotherapy Drugs Introduction
11.2.4 Pfizer Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Cancers Immunotherapy Drugs Introduction
11.3.4 Merck Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cancers Immunotherapy Drugs Introduction
11.4.4 Novartis Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Cancers Immunotherapy Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Cancers Immunotherapy Drugs Introduction
11.6.4 Sanofi Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Cancers Immunotherapy Drugs Introduction
11.7.4 GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancers Immunotherapy Drugs Introduction
11.8.4 Amgen Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.8.5 Amgen Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Cancers Immunotherapy Drugs Introduction
11.9.4 AbbVie Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.9.5 AbbVie Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Cancers Immunotherapy Drugs Introduction
11.10.4 Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.10.5 Boehringer Ingelheim Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Cancers Immunotherapy Drugs Introduction
11.11.4 AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.11.5 AstraZeneca Recent Development
11.12 Immatics Biotechnologies
11.12.1 Immatics Biotechnologies Company Details
11.12.2 Immatics Biotechnologies Business Overview
11.12.3 Immatics Biotechnologies Cancers Immunotherapy Drugs Introduction
11.12.4 Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2020-2025)
11.12.5 Immatics Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Pfizer Inc
Merck
Novartis
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Amgen Inc
AbbVie
Boehringer Ingelheim
Astrazeneca plc
Immatics Biotechnologies
List of Tables
 Table 1. Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Check Point Inhibitors
 Table 4. Key Players of Interferons
 Table 5. Key Players of Interleukins
 Table 6. Global Cancers Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancers Immunotherapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Cancers Immunotherapy Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Cancers Immunotherapy Drugs Market Share by Region (2020-2025)
 Table 10. Global Cancers Immunotherapy Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Cancers Immunotherapy Drugs Market Share by Region (2026-2031)
 Table 12. Cancers Immunotherapy Drugs Market Trends
 Table 13. Cancers Immunotherapy Drugs Market Drivers
 Table 14. Cancers Immunotherapy Drugs Market Challenges
 Table 15. Cancers Immunotherapy Drugs Market Restraints
 Table 16. Global Cancers Immunotherapy Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Cancers Immunotherapy Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Cancers Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancers Immunotherapy Drugs as of 2024)
 Table 19. Ranking of Global Top Cancers Immunotherapy Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Cancers Immunotherapy Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Cancers Immunotherapy Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Cancers Immunotherapy Drugs, Product and Application
 Table 23. Global Key Players of Cancers Immunotherapy Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Cancers Immunotherapy Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Cancers Immunotherapy Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Cancers Immunotherapy Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Cancers Immunotherapy Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Cancers Immunotherapy Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Cancers Immunotherapy Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Cancers Immunotherapy Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Cancers Immunotherapy Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Cancers Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Cancers Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Cancers Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Cancers Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Cancers Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Cancers Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Cancers Immunotherapy Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Cancers Immunotherapy Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Cancers Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Cancers Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancers Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Cancers Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Cancers Immunotherapy Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Roche Company Details
 Table 49. Roche Business Overview
 Table 50. Roche Cancers Immunotherapy Drugs Product
 Table 51. Roche Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 52. Roche Recent Development
 Table 53. Pfizer Company Details
 Table 54. Pfizer Business Overview
 Table 55. Pfizer Cancers Immunotherapy Drugs Product
 Table 56. Pfizer Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 57. Pfizer Recent Development
 Table 58. Merck Company Details
 Table 59. Merck Business Overview
 Table 60. Merck Cancers Immunotherapy Drugs Product
 Table 61. Merck Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 62. Merck Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Cancers Immunotherapy Drugs Product
 Table 66. Novartis Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. Johnson & Johnson Company Details
 Table 69. Johnson & Johnson Business Overview
 Table 70. Johnson & Johnson Cancers Immunotherapy Drugs Product
 Table 71. Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 72. Johnson & Johnson Recent Development
 Table 73. Sanofi Company Details
 Table 74. Sanofi Business Overview
 Table 75. Sanofi Cancers Immunotherapy Drugs Product
 Table 76. Sanofi Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 77. Sanofi Recent Development
 Table 78. GlaxoSmithKline Company Details
 Table 79. GlaxoSmithKline Business Overview
 Table 80. GlaxoSmithKline Cancers Immunotherapy Drugs Product
 Table 81. GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 82. GlaxoSmithKline Recent Development
 Table 83. Amgen Company Details
 Table 84. Amgen Business Overview
 Table 85. Amgen Cancers Immunotherapy Drugs Product
 Table 86. Amgen Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 87. Amgen Recent Development
 Table 88. AbbVie Company Details
 Table 89. AbbVie Business Overview
 Table 90. AbbVie Cancers Immunotherapy Drugs Product
 Table 91. AbbVie Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 92. AbbVie Recent Development
 Table 93. Boehringer Ingelheim Company Details
 Table 94. Boehringer Ingelheim Business Overview
 Table 95. Boehringer Ingelheim Cancers Immunotherapy Drugs Product
 Table 96. Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 97. Boehringer Ingelheim Recent Development
 Table 98. AstraZeneca Company Details
 Table 99. AstraZeneca Business Overview
 Table 100. AstraZeneca Cancers Immunotherapy Drugs Product
 Table 101. AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 102. AstraZeneca Recent Development
 Table 103. Immatics Biotechnologies Company Details
 Table 104. Immatics Biotechnologies Business Overview
 Table 105. Immatics Biotechnologies Cancers Immunotherapy Drugs Product
 Table 106. Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2020-2025) & (US$ Million)
 Table 107. Immatics Biotechnologies Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Cancers Immunotherapy Drugs Picture
 Figure 2. Global Cancers Immunotherapy Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancers Immunotherapy Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Check Point Inhibitors Features
 Figure 6. Interferons Features
 Figure 7. Interleukins Features
 Figure 8. Global Cancers Immunotherapy Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Cancers Immunotherapy Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Lung Cancer Case Studies
 Figure 11. Liver Cancer Case Studies
 Figure 12. Colorectal Cancer Case Studies
 Figure 13. Pancreatic Cancer Case Studies
 Figure 14. Breast Cancer Case Studies
 Figure 15. Other Cancers Case Studies
 Figure 16. Cancers Immunotherapy Drugs Report Years Considered
 Figure 17. Global Cancers Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Cancers Immunotherapy Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Cancers Immunotherapy Drugs Market Share by Region: 2024 VS 2031
 Figure 20. Global Cancers Immunotherapy Drugs Market Share by Players in 2024
 Figure 21. Global Top Cancers Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancers Immunotherapy Drugs as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Cancers Immunotherapy Drugs Revenue in 2024
 Figure 23. North America Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Cancers Immunotherapy Drugs Market Share by Country (2020-2031)
 Figure 25. United States Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Cancers Immunotherapy Drugs Market Share by Country (2020-2031)
 Figure 29. Germany Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Cancers Immunotherapy Drugs Market Share by Region (2020-2031)
 Figure 37. China Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Cancers Immunotherapy Drugs Market Share by Country (2020-2031)
 Figure 45. Mexico Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Cancers Immunotherapy Drugs Market Share by Country (2020-2031)
 Figure 49. Turkey Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Cancers Immunotherapy Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Roche Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 55. Novartis Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 56. Johnson & Johnson Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 57. Sanofi Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 58. GlaxoSmithKline Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 59. Amgen Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 60. AbbVie Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 61. Boehringer Ingelheim Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 62. AstraZeneca Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 63. Immatics Biotechnologies Revenue Growth Rate in Cancers Immunotherapy Drugs Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Tumor Immunotherapy Market
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intratumoral Cancer Therapies Market Research Report 2025
Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CAR T Cell Immunotherapies for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Generics Market
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Laser Cancer Therapy Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions